20-F XBRL

ANNUAL REPORT

Company: Can-Fite BioPharma Ltd.
Filed: March 30, 2023
Period of Report: December 31, 2022
Accession Number: 0001213900-23-024298

View Document ↗ View on SEC.gov ↗